| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 670121 | 11-Hydroxy aclacinomycin A | 0.0352028253287042 | 0.29098356 |
| NSC 672140 | Null | 0.0352028253287042 | 0.19013968 |
| NSC 685285 | Null | 0.0352028253287042 | 0.35320745 |
| NSC 685964 | Null | 0.0352028253287042 | 0.34243101 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0352028253287042 | 0.48304836 |
| NSC 706992 | Null | 0.0352028253287042 | 0.096104356 |
| NSC 726217 | Combretastatin A4-analogue | 0.0352028253287042 | 0.3535062 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0352028253287042 | 0.34017289 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0352028253287042 | 0.29142253 |
| NSC 730009 | cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0352028253287042 | 0.48837378 |